Use of Rituximab Compared to Anti-Tnf Agents As Second and Third Line Therapy in Patients with Rheumatoid Arthritis: A Report from the rhumadata® Clinical Database and registry.

被引：0

作者：

Choquette, Denis ^{[1
]}

Raynauld, Jean-Pierre ^{[1
]}

Pelletier, Jean Pierre ^{[1
]}

Haraoui, Boulos ^{[1
]}

Bessette, Louis ^{[2
]}

Villeneuve, Edith ^{[1
]}

Remillard, Marie-Anais ^{[1
]}

Fortin, Isabelle ^{[3
]}

Sauvageau, Diane ^{[1
]}

Coupal, Louis ^{[1
]}

机构：

[1] IRM, Montreal, PQ, Canada

[2] CORQ, Quebec City, PQ, Canada

[3] CREQ, Rimouski, PQ, Canada

来源：

ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1535

引用

页码：S676 / S676

页数：1

共 50 条

[11] Comparing abatacept to Adalimumab, Etanercept and Infliximab As First Or Second Line Agents in Patients With Rheumatoid arthritis: Experience From the rhumadata® Clinical Database and Registry
Choquette, Denis
Sauvageau, Diane
Bessette, Louis
Haraoui, Boulos
Pelletier, Jean Pierre
Raynauld, Jean-Pierre
Villeneuve, Edith
Coupal, Louis
ARTHRITIS AND RHEUMATISM, 2013, 65 : S186 - S186
[12] Comparing Abatacept to Adalimumab, Etanercept and Infliximab as First or Second Line Agents in Patients with Rheumatoid Arthritis. Experience from the RHUMADATA® Clinical Database and Registry
Coupal, Louis
Haraoui, Boulos
Bessette, Louis
Raynauld, Jean-Pierre
Pelletier, Jean-Pierre
Massicotte, Frederic
Remillard, Marie-Anais
Sauvageau, Diane
Villeneuve, Edith
Choquette, Denis
JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1314 - 1314
[13] COMPARING ABATACEPT TO ADALIMUMAB, ETANERCEPT AND INFLIXIMAB AS FIRST OR SECOND LINE AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS. EXPERIENCE FROM THE RHUMADATA® CLINICAL DATABASE AND REGISTRY
Fortin, I.
Choquette, D.
Bessette, L.
Haraoui, B.
Pelletier, J. -P.
Raynauld, J. P.
Remillard, M-A
Sauvageau, D.
Villeneuve, E.
Coupal, L.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 273 - 274
[14] USE OF ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE RHUMADATA DATABASE: EXPERIENCE AS FIRST OR SECOND LINE AGENT COMPARED WITH ADALIMUMAB AND ETANERCEPT
Choquette, D.
Sauvageau, D.
Haraoui, B.
Pelletier, J. -P.
Raynauld, J. -P.
Villeneuve, E.
Coupal, L.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 449 - 449
[15] Six Years Tocilizumab Use in Patients with Rheumatoid Arthritis with One Previous Anti-TNF Agent Exposure: Comparison with Adalimumab and Etanercept from the Provincial Electronic Database and Registry Rhumadata
Choquette, Denis
Bessette, Louis
Haraoui, Boulos
Massicotte, Frederic
Pelletier, Jean-Pierre
Raynauld, Jean-Pierre
Remillard, Marie-Anais
Brown, Jacques
Sauvageau, Diane
Villeneuve, Edith
Coupal, Louis
JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1213 - 1213
[16] SIX YEARS TOCILIZUMAB USE IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH ONE PREVIOUS ANTI-TNF AGENT EXPOSURE: COMPARISON WITH ADALIMUMAB AND ETANERCEPT FROM THE PROVINCIAL ELECTRONIC DATABASE AND REGISTRY RHUMADATA®
Bessette, L.
Brown, J.
Coupal, L.
Haraoui, B.
Massicotte, F.
Pelletier, J. -P.
Raynauld, J. -P.
Remillard, M. -A.
Sauvageau, D.
Villeneuve, E.
Choquette, D.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 190 - 190
[17] Tocilizumab use in Patients with Rheumatoid Arthritis having Failed One Previous Anti-TNF Agent: Comparison with Adalimumab, Etanercept and Infliximab from the Provincial Electronic Database and Registry Rhumadata®
Choquette, Denis
Bessette, Louis
Fortin, Isabelle
Haraoui, Boulos
Villeneuve, Edith
Massicotte, Frederic
Pelletier, Jean-Pierre
Raynauld, Jean-Pierre
Remillard, Marie-Anais
Sauvageau, Diane
Coupal, Louis
JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1298 - 1299
[18] Anti-TNFα therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes
Bazzani, Chiara
Filippini, Matteo
Caporali, Roberto
Bobbio-Pallavicini, Francesca
Favalli, Ennio Giulio
Marchesoni, Antonio
Atzeni, Fabiola
Sarzi-Puttini, Piercarlo
Gorla, Roberto
AUTOIMMUNITY REVIEWS, 2009, 8 (03) : 260 - 265
[19] Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF alpha blocker failure
Kekow, Joern
Mueller-Ladner, Ulf
Schulze-Koops, Hendrik
BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 191 - 199
[20] A STUDY OF ANTI-TNF THERAPY USE FOR RHEUMATOID ARTHRITIS PATIENTS IN WALES
Dutta, Shouma
RHEUMATOLOGY, 2009, 48 : I61 - I62

← 1 2 3 4 5 →